Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Decreases Listeria monocytogenes - : 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} |
📓
Characterization of indigenous lactobacillus strains for probiotic properties. Jundishapur journal of microbiology (Jundishapur J Microbiol ) Vol: 8 Issue 2 Pages: e17523 Pub: 2015 Feb Epub: 2015 Feb 7 Authors Mojgani N , Hussaini F , Vaseji N , Html Article Publication |
Decreases Listeria monocytogenes - : 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} |
📓
Fisetin inhibits Listeria monocytogenes virulence by interfering with the oligomerization of listeriolysin O. The Journal of infectious diseases (J Infect Dis ) Vol: 211 Issue 9 Pages: 1376-87 Pub: 2015 May 1 Epub: 2014 Sep 17 Authors Wang J , Qiu J , Tan W , Zhang Y , Wang H , Zhou X , Liu S , Feng H , Li W , Niu X , Deng X , Publication |
Decreases Listeria monocytogenes - : 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxychromen-4-one {Fisetin} |
📓
Fisetin Protects Against Listeria monocytogenes Infection by Reducing the Production of Listeriolysin O. The Journal of infectious diseases (J Infect Dis ) Vol: 213 Issue 4 Pages: 684-5 Pub: 2016 Feb 15 Epub: 2015 Sep 7 Authors Loose M , Pillich H , Chakraborty T , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]